All Pharma articles
See all articles with this subject.
-
HSJ PartnersDemystifying NHS-pharmaceutical industry collaboration: Unlocking value already within reach
This non-promotional article has been fully funded and written by Novartis Pharmaceuticals UK Limited. It is intended for healthcare professionals, other relevant decision makers and patient organisations. Please do not forward, share or post this content beyond the intended audience, including on publicly accessible websites or ...
-
HSJ PartnersUnderstanding the impact of severe asthma to improve patient outcomes
As medical head, specialty at GSK, my work keeps me close to both the lived reality of severe asthma and the system pressures it creates.
-
NewsEx-NHSE director joins NICE top team
The National Institute for Health and Care Excellence has appointed a GP, and former NHS England national clinical director, as its new chief medical officer.
-
HSJ PartnersWorking in partnership to achieve hepatitis C elimination
An unprecedented partnership approach with Gilead Sciences has helped put the UK on track to be one of the first countries to eliminate hepatitis C
-
HSJ PartnersBeyond the minimum: Broadening the field of vision for neighbourhood health
The NHS has been clear about what it wants neighbourhood health to deliver. To succeed, it must be built on the deliberate use of the full breadth of primary care and community partners.
-
CommentBoth government and trusts are to blame for failing MND patients
The programme designed to give early access to an innovative new drug for motor neurone disease is not operating properly
-
Comment‘Cheapest is best’ is still dominating NHS procurement
When buying things, the NHS has focused too much on lowest price, rather than best value. Ministers must not miss the opportunity to put this right
-
NewsFridge door left ajar cost trust £25k
An acute trust was forced to write off £25,000 worth of medication after a pharmacy fridge door was accidentally left ajar.
-
NewsHospitals must update 100,000 pacemakers after safety fault
Hospitals are having to update more than 100,000 patients’ pacemakers – and replace hundreds of the devices – after the manufacturer discovered their batteries run down years early, HSJ has learned.
-
News£340k remuneration deal fails to attract DHSC growth director
The Department of Health and Social Care has failed to find a substantive director general for commercial and growth, despite offering potentially the largest pay packet in the DHSC.
-
CommentWhen safety does not sell
Despite decades of inquiries and warnings, the NHS continues to tolerate predictable medication harm, revealing a system better at analysing failure than preventing it
-
NewsExclusive: DHSC appoints interim commercial chief
The Department of Health and Social Care has appointed an interim director general to run its commercial and growth directorate until July.
-
HSJ PartnersWhat can ctDNA tell us about a patient’s cancer?
Circulating tumour DNA (ctDNA) is transforming how we diagnose and treat complex cancers, particularly when clinical pathways are constrained by the speed, safety, and limitations of tissue biopsy.
-
CommentWhy pharmacy is still excluded from neighbourhood care
Community pharmacy is one of the NHS’s most accessible assets, yet it remains largely excluded from new integrated care models.
-
NewsRegion seeks firm to replace ‘ageing critical infrastructure’
Six trusts in the West Midlands are letting a £290m contract to build and run a regional sterile drugs production unit, to replace current outdated facilities.
-
HSJ PartnersBeyond the attack count: Turning shared decision making into a reality in HAE care
For individuals living with hereditary angioedema (HAE) in the UK, their journey often begins with uncertainty, misdiagnosis and fragmented care.
-
NewsTrump drug deal to leave NHS with unfunded bill
The NHS is seeking further funding from government to help it absorb extra costs arising from a new drug pricing deal, partly inspired by the threat of tariffs on UK medicines made by US president Donald Trump.
-
NewsLocal systems must ‘comply’ with new medicines access policy
NHS England wants to standardise local drug formulary teams and operations while it develops a single national formulary over the next two years, HSJ has learned.
-
HSJ PartnersBehind every prescription is a person: reframing medicines optimisation for patient-centric impact in the NHS
Aspire Pharma Ltd initiated and funded this article but had no input into the content and was able to review it in advance of publication for factual accuracy and compliance checks only. Within the NHS, medicines are still too often discussed through the narrow lens of cost. Budgets ...
-
CommentPharma is working to boost drug availability, not prices
Victoria Jordan, director of value and access policy at the Association of the British Pharmaceutical Industry (ABPI), explores how medicine pricing affects patient access, research investment, and the sustainability of the UK health system